Mercer Global Advisors Inc Pds Biotechnology Corp Transaction History
Mercer Global Advisors Inc
- $48.3 Billion
- Q2 2025
A detailed history of Mercer Global Advisors Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 12,510 shares of PDSB stock, worth $11,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,510
Previous 12,500
0.08%
Holding current value
$11,259
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PDSB
# of Institutions
58Shares Held
7.68MCall Options Held
98.2KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$2.01 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.76 Million0.0% of portfolio
-
Ubs Group Ag543KShares$488,7180.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$438,2700.0% of portfolio
-
Geode Capital Management, LLC Boston, MA418KShares$376,1400.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $25.6M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...